Across TCGA cell cohorts, PSG9 mutation is significantly associated with the RNA expression of many other genes, with 34 significant associations in total. LUNG_NSCLC_LUAD shows the largest number of these associations.

The most reproducible PSG9-associated genes across cancer lineages are PRY2, PRR23B, and OR2M3. Each is linked with PSG9 in more than 1 cancer types. Because this analysis shows association rather than direction, both PSG9-to-partner and partner-to-PSG9 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PSG9→partner) and Y-score (partner→PSG9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLOOD_Lymphoma	PRY2 →	+0.029	+4.058	<.001	.009	3	1
BLOOD_Lymphoma	PRR23B →	+0.004	+4.662	<.001	.003	3	1
BLOOD_Lymphoma	OR2M3 →	+0.019	+4.606	.001	.001	3	1
BLOOD_Lymphoma	SLC13A1 →	+0.011	+3.927	<.001	.004	3	1
LUNG_NSCLC_LUAD	PRSS54 →	+0.034	+3.734	.001	.006	3	1
LUNG_NSCLC_LUAD	DEFB126 →	+0.601	+4.215	<.001	.002	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 34 associations by consensus.

Exploration

PSG9 survival (RNA) · tumor vs normal (RNA) · all PSG9 data types